Lumea Integration &
Join us in creating the future of digital pathology
and improving patient outcomes
Artificial Intelligence Partners
AI algorithms available on our platform
Visit Artera
Cancer is personal.
Cancer therapy should be, too.
Our multimodal AI test provides individualized results, enabling personalized treatment decision-making between clinicians and patients.
Visit Deep Bio
Deep Bio strives to achieve the highest level of accuracy, sensitivity and specificity by our AI software to become a reliable partner for our users and create values for the healthcare industry.
With the power of AI, we now have the ability to ACCELERATE the discovery of novel targets,PREDICT the effectiveness of treatments, IDENTIFY potentially life-saving clinical trials, DIAGNOSE multiple diseases earlier.
We deliver cutting-edge artificial intelligence solutions for healthcare and life sciences applications. Our innovative products and services drive efficiency, enhance diagnostic accuracy, and provide data-driven insights from digitally scanned images.
As longstanding leaders in AI, Paige was among the first to apply the power of foundation models to cancer care and have since delivered numerous models that set new standards for size, scale and performance.
We develop an AI-based platform for automated and accurate cancer diagnosis. This technology, leveraging image analysis and deep learning, improves the detection of major cancer biomarkers and guides personalized treatment.
We offer ready-to-use solutions because the demand for the expert evaluation of histopathology images is strongly increasing while the number of pathologists remains constant.
Quantitative and qualitative data from our AI-powered computational platform enhances cytology insights to improve workflows and quality of patient care in the battle against cancer.
Our diagnostics use AI to interpret solid tumors, so physicians and patients can make evidence-based decisions about cancer treatments
LIS & EMR
Integrations & Collaborations
LigoLab supports and streamlines the complete life-cycle of laboratory and financial operations. Intuitive and easy to learn, it’s accessible from anywhere at any time and scalable as you grow.
Visit Vitalaxis
Revolutionizing Laboratories and Practices through Innovative Cloud-Based Healthcare IT Products and Services
Visit ModMed
All-in-one. Customizable. Powered by AI.
Specialty-specific EHR software that knows your workflow
Scanners
Lumea is scanner agnostic, with integrations spanning over 75 scanners across 25 different makes and models.
The vendors below are among our preferred partners.
Visit Hamamatsu
The NanoZoomer Series is a family of whole slide scanners that convert glass slides into high-resolution digital data by high-speed scanning.
Visit Roche
A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That’s what makes us Roche.
Quality you can see. With over 380 image capture technology patents and world-leading optics, our system enables precise, high-resolution capture of whole slide details—for brightfield, fluorescent, or FISH samples.
Pathology is just embarking on its digitization journey, and there are multiple ways that departments can promote interoperability in partnership with industry. Standardizing whole slide image formats and promoting tight integration between different software systems will benefit not just individual users but also healthcare systems.
Grundium’s digital pathology scanners are designed to make slide scanning effortless, whether for networked clinics or individual labs. Compact, fast, and precise, they empower medical professionals worldwide to deliver accurate diagnoses faster.
Pramana’s modular scanner systems feature identical optical paths, uniform software, and a seamless user experience.
Molecular Testing
Molecular tests available on our platform
for simplified ordering
Understanding our unique genetic and genomic blueprint unlocks powerful, personalized insights that help patients and healthcare providers detect health risks, tailor treatments, and prevent disease with precision.
Cxbladder is a suite of non-invasive genomic urine tests optimized for the risk stratification of urothelial cancer in patients presenting with microhematuria and those being monitored for recurrent disease.
At Veracyte, we are committed to advancing personalized care for urologic cancers like prostate cancer and bladder cancer.
Visit Caris
Where Molecular Science Meets Artificial Intelligence
ZX Improving the earlier detection of aggressive prostate cancer and urologic diseases with personalized molecular diagnostic solutions
Together, Invitae (“in-VEE-tay”) and Labcorp make it easier to access genetic data, uncover personal health insights and deliver the right care for each patient’s needs.
We’re transforming cancer care by delivering tomorrow’s answers today.
At the heart of successful Pathology Labs
Improve risk assessment to better inform your prostate biopsy decision‑making.
Next Generation Multi-Omics & Biomarker Profiling
directly from routine tissue images
“Everyone talks about collaboration, but Lumea clearly has it embedded in its DNA. It’s incredibly exciting to see this ethos attract such a diverse, driven, and capable group, each looking not to outdo the other but to bring their strengths to the arena and push for a better future.”
Dr. John Salmon, MDSalmon Upstream, LLC
